No Data
Express News | HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $33 Price Target
Promising Interim Results Propel Purple Biotech's Buy Rating Amid Phase 2 Success and Strategic Advancements
Purple Biotech's Promising Trials and Financial Update
Purple Biotech GAAP EPS of -$0.39
Purple Biotech | 6-K: Report of foreign private issuer (related to financial reporting)
Express News | Purple Biotech Ltd: Qtrly Loss per Ads $4.57